Navigation Links
DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
Date:1/24/2013

New York, NY (PRWEB) January 24, 2013

The prescription drug resource center DrugRisk.com is alerting women who have used the vaginal ring contraceptive NuvaRing of new information added to the site showing trials are scheduled to begin this year for those claiming they suffered blood clots from the devices.

The mission of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. “Many patients follow legal news for a drug they’re using to learn if others may be affected with similar problems and whether they have options,” explains DrugRisk representative Ryan Mayer.

DrugRisk contains warnings from experts linking vaginal rings like NuvaRing to higher blood clot risks than traditional birth control pills.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives.* On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.** Nevertheless, there has still been no NuvaRing recall.

DrugRisk has also learned that, due to the number of patients filing a NuvaRing lawsuit, cases have been consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Now, new information on the site shows that Judge Rodney Sippel, who is presiding over the federal court, has scheduled trials to begin on July 8, 2013.*** The latest U.S. Judicial Panel on MultiDistrict Litigation update showed NuvaRing lawsuits have risen by nearly 5% to 1076.****

This month, DrugRisk learned of research at Brigham and Women’s Faulkner Hospital which found that, while combined hormone vaginal ring contraceptives like NuvaRing can increase blood clot risks for all women, the risks are significantly higher for those suffering migraines.*****

Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*bmj.com/content/344/bmj.e2990
**nejm.org/doi/full/10.1056/NEJMoa1111840
***Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf
*****foxnews.com/health/2013/01/15/migraines-with-aura-linked-to-heart-disease/

Read the full story at http://www.prweb.com/releases/nuvaring-recall/lawsuit-warnings/prweb10348434.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces New Pradaxa Health Warning From Australia
2. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
5. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
6. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
7. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
8. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
9. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
10. Skechers Lawsuit on Behalf an Ohio Woman Who Sustained Serious Ankle Injury Allegedly Due to Shape-Ups' Defective Design Filed by Wright & Schulte LLC
11. New Class Action Lawsuit on Toddler’s Severe Burns from Glass-Fronted Fireplace: Now, AttorneyOne Can Provide Advice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: